Related Experiment Videos
New model of ventricular fibrillation
André Ferrari de França Camargo1, Anezka Carvalho Rubin de Celis, Irineu Tadeu Velasco
1Emergency Department Research Laboratory, University of São Paulo School of Medicine, CEP: 05403-010 São Paulo, Brazil. andreferrari@mensa.org.br
Journal of Electrocardiology
|July 9, 2005
Summary
This study developed a stable rabbit heart model for ventricular fibrillation (VF). High extracellular calcium prolonged VF but hindered reversion to sinus rhythm, impacting antiarrhythmic drug studies.
Area of Science:
- Cardiovascular Physiology
- Cardiac Electrophysiology
Background:
- Developing a stable and efficient ventricular fibrillation (VF) model in isolated rabbit hearts is crucial for studying antiarrhythmic interventions.
- Existing models often lack the necessary stability and duration for comprehensive research.
Purpose of the Study:
- To establish a more efficient and stable model of VF in isolated rabbit hearts.
- To investigate the impact of elevated extracellular calcium on VF stability and reversibility.
Main Methods:
- Isolated rabbit hearts were subjected to burst stimulation to induce VF using a Langendorff preparation.
- Two groups were formed: Group A (standard Krebs-Henseleit solution) and Group B (modified solution with double calcium concentration).
- VF duration and reversibility to sinus rhythm upon drug administration were assessed.
Main Results:
- The model achieved 100% success in inducing VF in both groups.
- Ventricular fibrillation persisted for over 30 minutes in Group A and over 40 minutes in Group B, exceeding previous studies.
- While VF was reversible with antiarrhythmic drugs in 100% of Group A hearts, no reversion occurred in Group B.
Conclusions:
- Elevated extracellular calcium significantly increases the stability and duration of VF in this model.
- High extracellular calcium impedes the reversion of VF to sinus rhythm, complicating antiarrhythmic interventions.
- This enhanced rabbit heart model provides a robust platform for evaluating antiarrhythmic agents.